Leon Kircik, MD
Enriched profileAssociate Clinical Professor of Dermatology · Icahn School of Medicine at Mount Sinai
Leon Kircik is Associate Clinical Professor of Dermatology at Icahn School of Medicine at Mount Sinai. OpenAlex indexes 587 publications with 8,336 citations (h-index 38); ClinicalTrials.gov lists 14 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Dermatology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 14 Oct 2026
Leon H. Kircik, MD, is Associate Clinical Professor of Dermatology at Icahn School of Medicine at Mount Sinai (Waldman Department of Dermatology). The public record shows 587 publications with 8,336 citations (h-index 38), centered on Dermatology and Skin Diseases, Acne and Rosacea Treatments and Effects, Psoriasis: Treatment and Pathogenesis. It also documents an investigator role on 14 registered clinical trials, industry payments reported by 45 companies.
- Most recent indexed publication: 2026 · Acta dermato-venereologica
- Top research focus: Dermatology and Skin Diseases
- 14 registered trials on ClinicalTrials.gov
- Open Payments reporting from 45 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 7 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 160.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 14 registered studies on ClinicalTrials.gov. The most recent:
- Efficacy and Safety of Sorilux in Maintenance Treatment of Moderate Type Plaque Psoriasis
Sponsor: Skin Sciences, PLLC
- The Use of Oracea and Epiduo Forte in Severe Acne Patients
Sponsor: Derm Research, PLLC
- Use of Apremilast in Patients Who Are Dissatisfied With Stable Maintenance Topical Therapy
Sponsor: Derm Research, PLLC
Industry payments
Updated 14 Oct 2026
45 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- SUN PHARMACEUTICAL INDUSTRIES INC.Program year202591 payments$130,302openpaymentsdata.cms.gov ↗
- Lilly USA, LLCProgram year202559 payments$98,263openpaymentsdata.cms.gov ↗
- UCB, Inc.Program year2025111 payments$91,329openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
100%Corticosteroid100%Triamcinolone Acetonide100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials.
Acta dermato-venereologica
Clinical Trial2026 - Efficacy and safety of rilzabrutinib in patients with moderate-to-severe atopic dermatitis: 16-week results from a proof-of-concept phase II clinical trial.
The British journal of dermatology
Clinical Trial2025 - Deucravacitinib: Laboratory Parameters Across Phase 3 Plaque Psoriasis Trials.
Dermatology and therapy
Article2025
Most-cited works
by citation count (OpenAlex)Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- ResearchGate
researchgate.net/profile/Leon-Kircik
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - Doximity
doximity.com/pub/leon-kircik-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/leon-kircik-84020b158
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- Instagram
instagram.com/idef_derm/p/C7JsDtDLotO
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →instagram.com ↗ - X / Twitter
x.com/MSHSDerm/status/1988643112760316084/photo/1
- X / Twitter
x.com/MSHSDerm/status/1996723730211344401
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
SUNY Downstate Medical Center (State University of New York Health Science Center at Brooklyn), graduated with AOA Honors
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aocd.org ↗ - Dermatology Residency
SUNY Health Science Center at Buffalo
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dermsquared.com ↗ - Mohs Micrographic Surgery and Cutaneous Oncology Fellowship
University of Wisconsin Hospital
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dermsquared.com ↗ - Board Certified
American Board of Dermatology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.mssm.edu ↗
Editorial & leadership roles
journal and society appointments- Principal Investigator
numerous industry-sponsored clinical trials in psoriasis, acne, rosacea, atopic dermatitis, skin cancers, and actinic keratosis
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dermsquared.com ↗
Awards & honors
honors on the public record- Alpha Omega Alpha (AOA) Honors
SUNY Health Science Center at Brooklyn
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aocd.org ↗ - Fellow
American Academy of Dermatology (FAAD)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aocd.org ↗
Secondary affiliations
appointments beyond the home institution- Medical Director
DermResearch, PLLC / Physicians Skin Care, PLLC / Skin Sciences, PLLC, Louisville, KY
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dermsquared.com ↗ - Clinical Associate Professor of Dermatology
Indiana University School of Medicine, Indianapolis, IN
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dermsquared.com ↗
Media & interviews
press, podcasts and appearances- Guest
"The Life of Leon: How He Succeeds and Makes It Look Easy," Derms and Conditions podcast (hosted by James Q. Del Rosso, DO), May 7
2026verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗ - Interviewee
"Q&A: Reframing JAK Inhibitor Safety and Flexibility in AD With Leon Kircik, MD," Dermatology Times
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dermatologytimes.com ↗ - Featured author/contributor
HCPLive (video and written commentary on dermatologic conditions)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hcplive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Jonathan Halperin, MD
Icahn School of Medicine at Mount Sinai
Fred Lublin, MD
Icahn School of Medicine at Mount Sinai
Sundar Jagannath, MD
Icahn School of Medicine at Mount Sinai
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania